Mammalian Cdk5 Is a Functional Homologue of the Budding Yeast Pho85 Cyclin-Dependent Protein Kinase

Total Page:16

File Type:pdf, Size:1020Kb

Mammalian Cdk5 Is a Functional Homologue of the Budding Yeast Pho85 Cyclin-Dependent Protein Kinase Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase Dongqing Huang*, Gentry Patrick†, Jason Moffat*, Li-Huei Tsai†, and Brenda Andrews*‡ *Department of Molecular and Medical Genetics, University of Toronto, 1 Kings College Circle, Toronto, Canada M5S 1A8; and †Howard Hughes Medical Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115 Edited by Ira Herskowitz, University of California, San Francisco, CA, and approved October 13, 1999 (received for review May 26, 1999) Mammalian Cdk5 is a member of the cyclin-dependent kinase display a broad spectrum of phenotypes, including slow growth family that is activated by a neuron-specific regulator, p35, to in rich medium, derepressed acid phosphatase activity, hyper- ͞ regulate neuronal migration and neurite outgrowth. p35 Cdk5 accumulation of glycogen, and defects in G1 progression and kinase colocalizes with and regulates the activity of the Pak1 kinase actin cytoskeleton regulation (11–15). Consistent with the mul- in neuronal growth cones and likely impacts on actin cytoskeletal tifunctional nature of Pho85, 10 genes encoding known or dynamics through Pak1. Here, we describe a functional homologue putative Pho85 cyclins (Pcls) have been identified (16). Expres- of Cdk5 in budding yeast, Pho85. Like Cdk5, Pho85 has been sion of three of the PCLs—PCL1, PCL2, and PCL9—is cell implicated in actin cytoskeleton regulation through phosphoryla- cycle-regulated with peak transcript levels in G1 phase, whereas tion of an actin-regulatory protein. Overexpression of CDK5 in expression of other Pho85 cyclins is constant through the cell yeast cells complemented most phenotypes associated with cycle. pho85⌬, including defects in the repression of acid phosphatase Like Cdk5, Pho85 plays important roles in polarized cell expression, sensitivity to salt, and a G1 progression defect. Con- growth and cytoskeletal dynamics. Yeast strains lacking PCL1,2- sistent with the functional complementation, Cdk5 associated with like cyclins are morphologically abnormal and display pheno- and was activated by the Pho85 cyclins Pho80 and Pcl2 in yeast types consistent with a disruption of the actin cytoskeleton (11, cells. In a reciprocal series of experiments, we found that Pho85 16, 17). Pcl-Pho85 kinases contribute to actin regulation at least associated with the Cdk5 activators p35 and p25 to form an active in part through phosphorylation of the Rvs167 protein (11). kinase complex in mammalian and insect cells, supporting our Rvs167 is a modular protein composed of at least three distinct hypothesis that Pho85 and Cdk5 are functionally related. Our protein-interaction domains and likely functions in multiprotein results suggest the existence of a functionally conserved pathway complexes to regulate actin polarization (17, 18). Among Cdks, involving Cdks and actin-regulatory proteins that promotes reor- Pho85 is most closely related to Cdk5, with 56% identity and ganization of the actin cytoskeleton in response to regulatory 72% similarity at the primary amino acid level. To explore the signals. functional significance of the protein sequence similarity be- tween Pho85 and Cdk5, and their similar roles in the regulation yclin-dependent kinases (Cdks) comprise a large family of of asymmetric growth, we used in vivo complementation assays Cproteins whose members are well known as key regulators and in vitro reconstitution to show that Pho85 and Cdk5 are that promote cell cycle progression in eukaryotic cells (reviewed functional homologues. Our observations led us to propose the in ref. 1). Recent studies have highlighted roles for Cdks in existence of a functionally conserved regulatory pathway, in- postmitotic cells, in gene expression, and in cell regulation volving cyclin-dependent kinases and their targets, that regulates beyond cell cycle control (2, 3). Although highly homologous to the actin cytoskeleton in response to regulatory stimuli. other members of the Cdk family, mammalian Cdk5 has no Materials and Methods known function in proliferative cells. Rather, Cdk5-associated Yeast Strains and Media. The wild-type (BY263, MATa trp1⌬63 kinase activity is restricted to postmitotic neurons and Cdk5 is ⌬ ⌬ ⌬ required for histogenesis of the central nervous system and leu2- 1 his3 200 ura3–52 lys2 ade2) and pho85 strains (BY391, neurite outgrowth (2, 4–6). Cdk5 phosphorylates syntaxin 1, pho85::LEU2, otherwise isogenic to BY263) have been de- Munc18, and synapsin I (7, 8), suggesting a regulatory role for scribed (16). We used a PCR-based strategy to target a triple- actin cytoskeletal dynamics. In the growth cones of cultured hemagglutinin (HA) epitope tag to the N-terminal coding cortical neurons, Cdk5 and its neuron-specific activator, p35, sequence of PCL2 in strain BY263. PCR conditions were as colocalize with actin filaments at the growth cone periphery (5). described by using plasmid pFA6a-kanMX6-PGAL1–3HA as More recently, p35͞Cdk5 was shown to colocalize with two template (19). The epitope-tagged allele of PCL2 is express- actin-regulatory proteins, the Rho-type GTPase Rac and the ed from the inducible GAL promoter (strain 263HA- PCL2, BY1116, MATa trp1 leu2 his3 ura3 lys2 ade2 Pak1 kinase, in neuronal growth cones (9). Phosphorylation of r Pak1 kinase by p35-Cdk5 may contribute to the reorganization pcl2::pGAL-HA-PCL2::Kan ). A pho85 deletion strain carrying of the actin cytoskeleton that occurs during neurite outgrowth the tagged PCL2 allele (pho85HA-PCL2, BY1129) was con- structed by crossing strain 263HA-PCL2 to strain BY864 and neuronal migration. ⌬ In the budding yeast Saccharomyces cerevisiae, two Cdk com- [pho85 TRP1 (11)]. Strain BY794 was used to assay comple- plexes, Cln-Cdc28 and Pcl-Pho85, have been implicated in the mentation of the G1 arrest phenotype in a pho85 cln1 cln2 mutant and had the following genotype: cln1⌬TRP1 cln2⌬LEU2 GENETICS regulation of the actin cytoskeleton. The Cdc28 kinase is re- ⌬ sponsible for cell cycle transitions and can be activated by nine pho85 LEU2 (pMETpho85ts17-HIS3), otherwise isogenic to cyclin regulatory subunits, the Clns and the Clbs (reviewed in ref. 3). Inappropriate expression of Cln-Cdc28 kinases leads to This paper was submitted directly (Track II) to the PNAS office. altered bud emergence, suggesting a role for Cdc28 in regulating Abbreviations: Cdk, cyclin-dependent kinase; Pcl, Pho85 cyclin; HA, hemagglutinin; GST, cell polarity and budding (10). The Pho85 Cdk is also activated glutathione S-transferase. by multiple cyclins and has roles in both cell cycle control and ‡To whom reprint requests should be addressed. E-mail: [email protected]. metabolic processes (3). Although PHO85 is not an essential The publication costs of this article were defrayed in part by page charge payment. This gene, it is required for viability in some stress conditions, such article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. as growth after starvation (11). In addition, pho85 mutants §1734 solely to indicate this fact. PNAS ͉ December 7, 1999 ͉ vol. 96 ͉ no. 25 ͉ 14445–14450 Downloaded by guest on September 29, 2021 BY263. A slt2⌬LEU2 pho85⌬TRP1 strain was constructed by mating strains Y782 [slt2⌬LEU2 (20)] and BY864 (pho85⌬TRP1). The resulting diploid strain was transformed with either plasmid pGALCDK5 (see below, pCDK5) or pGAL- PHO85-HIS3 (12), and pho85 slt2 double mutants were recov- ered by dissecting tetrads on galactose medium. Yeast cells were grown in supplemented minimal medium with either 2% dex- trose (SD) or galactose (SG). Low- and high-phosphate SG media were prepared by using phosphate-depleted yeast nitro- gen base and KH2PO4 supplements. Salt-containing medium was prepared by addition of NaCl to 0.75 M. COS-7 and Insect Cell Culture. COS-7 cells were maintained in DMEM supplemented with 10% calf serum and penicillin͞ streptomycin. Transient transfections of pCDNA3-based p35, p25, Cdk5, and PHO85 expression constructs in COS-7 cells were performed by using standard calcium phosphate methods. Hi5 insect cells were maintained in Grace’s Insect media and were infected with baculovirus 24 hr before harvesting for lysate preparation. Fig. 1. Biochemical and genetic complementation of the acid phosphatase Plasmids. To express PHO80 from the GPD promoter in yeast, an regulation defect in a pho85⌬ mutant by Cdk5 expression. (A) Complemen- HA tagged-PHO80 allele (21) was cloned into vector pBA230v tation of defect in acid phosphatase regulation. Acid phosphatase activity was (ATCC no. 87357, 2-␮, TRP1, GPD promoter) to create plasmid measured in pho85⌬ strains containing pCDK5 or pCDK5-I and a PHO80 pGPDPHO80 (pBA1276). Likewise, plasmid pBA230v-p35 expression plasmid (pPho80) or a control vector (p230v). Acid phosphatase (pBA1277) was constructed by subcloning the p35 gene from activity from a wild-type strain is also shown (wt). These strains were grown in plasmid pcDNA3-p35 (see below) into pBA230v. Vectors for repressed (7.4 mM phosphate, shaded bars) and derepressed (3.7 ␮M phos- expressing CDK5 (pMR438PSS) and antisense CDK5 (CDK5-I, phate, solid bars) conditions. Values are normalized for cell density (OD600). (B) pMR438SSP) from the GAL promoter in yeast have been Pho4 kinase assays with HA-Pho80-Cdk5. HA-Pho80 was immunoprecipitated described (22). A PHO85 expression plasmid was constructed by from yeast extracts and used in kinase assays with Pho4 as substrate. The ␮ following strains were used for extract preparation: lane
Recommended publications
  • PI3K Catalytic Isoform Alteration Promotes the LIMK1-Related
    ANTICANCER RESEARCH 37 : 1805-1818 (2017) doi:10.21873/anticanres.11515 PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells GA BIN PARK 1 and DAEJIN KIM 2 1Department of Biochemistry, Kosin University College of Medicine, Busan, Republic of Korea; 2Department of Anatomy, Inje University College of Medicine, Busan, Republic of Korea Abstract. Aim: To investigate the molecular mechanisms Several studies have shown a strong correlation between by which long-term exposure to cigarette smoke extract cigarette smoke (CS) and cancer metastasis through the (CSE) contributes to ovarian cancer metastasis. Materials induction of numerous factors involved in migration activity and Methods: Western blot analysis for diverse p110 (1-3). The exposure to CS induces the epithelial- isoforms of phosphoinositide 3-kinase (PI3K)-related mesenchymal transition (EMT) process and up-regulates the signaling pathway and epithelial-mesenchymal transition expression of EMT markers, including N-cadherin and (EMT) markers was performed to analyze the underlying vimentin (4, 5). Cigarette smoke extract (CSE) treatment mechanisms. Migratory activity of CSE-exposed ovarian significantly induces interleukin-8 (IL-8) and transforming cancer cells was determined by transendothelial migration growth factor-beta 1 (TGF- β1 ) production and profoundly and invasion assay. Results: After exposure to CSE for four suppresses the proliferation and growth of erythroid and weeks, CaOV3 (primary) and SKOV3 (metastatic) ovarian granulocyte-macrophage progenitors (6). Stimulation with cancer cells showed enhanced mesenchymal characteristics CSE in human lung fibroblast cells induces the expression and produced EMT-related cytokines [intwerleukin-8 (IL-8), of phosphorylated Smad3, a main downstream target of the vascular endothelial growth factor (VEGF) and TGF- β1 receptor, which results in the secretion of vascular transforming growth factor-beta 1 (TGF- β1 )].
    [Show full text]
  • Circular RNA Hsa Circ 0005114‑Mir‑142‑3P/Mir‑590‑5P‑ Adenomatous
    ONCOLOGY LETTERS 21: 58, 2021 Circular RNA hsa_circ_0005114‑miR‑142‑3p/miR‑590‑5p‑ adenomatous polyposis coli protein axis as a potential target for treatment of glioma BO WEI1*, LE WANG2* and JINGWEI ZHAO1 1Department of Neurosurgery, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033; 2Department of Ophthalmology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin 130021, P.R. China Received September 12, 2019; Accepted October 22, 2020 DOI: 10.3892/ol.2020.12320 Abstract. Glioma is the most common type of brain tumor APC expression with a good overall survival rate. UALCAN and is associated with a high mortality rate. Despite recent analysis using TCGA data of glioblastoma multiforme and the advances in treatment options, the overall prognosis in patients GSE25632 and GSE103229 microarray datasets showed that with glioma remains poor. Studies have suggested that circular hsa‑miR‑142‑3p/hsa‑miR‑590‑5p was upregulated and APC (circ)RNAs serve important roles in the development and was downregulated. Thus, hsa‑miR‑142‑3p/hsa‑miR‑590‑5p‑ progression of glioma and may have potential as therapeutic APC‑related circ/ceRNA axes may be important in glioma, targets. However, the expression profiles of circRNAs and their and hsa_circ_0005114 interacted with both of these miRNAs. functions in glioma have rarely been studied. The present study Functional analysis showed that hsa_circ_0005114 was aimed to screen differentially expressed circRNAs (DECs) involved in insulin secretion, while APC was associated with between glioma and normal brain tissues using sequencing the Wnt signaling pathway. In conclusion, hsa_circ_0005114‑ data collected from the Gene Expression Omnibus database miR‑142‑3p/miR‑590‑5p‑APC ceRNA axes may be potential (GSE86202 and GSE92322 datasets) and explain their mecha‑ targets for the treatment of glioma.
    [Show full text]
  • Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry Into Bladder Cancer Cells
    Cancer Molecular and Cellular Pathobiology Research Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells Gil Redelman-Sidi1,2, Gopa Iyer3,4, David B. Solit3,4, and Michael S. Glickman1,2 Abstract Bacille Calmette-Guerin (BCG) is an attenuated strain of Mycobacterium bovis that is used widely as a vaccine for tuberculosis and is used as an effective treatment for superficial bladder carcinoma. Despite being the most successful cancer biotherapy, its mechanism of action and response determinants remain obscure. Here, we establish a model system to analyze BCG interaction with bladder cancer cells, using it to show that these cells vary dramatically in their susceptibility to BCG infection. Unexpectedly, the uptake of BCG by bladder cancer cells occurs by macropinocytosis rather than phagocytosis. BCG entry into bladder cancer cells relied upon Rac1, Cdc42, and their effector kinase Pak1. The difference in susceptibility between BCG- permissive and -resistant bladder cancer cells was due to oncogenic activation of signaling pathways that activate macropinocytosis, with phosphoinositide 3-kinase inhibitor activation stimulating BCG uptake independently of Akt. Similarly, activated Ras strongly activated Pak1-dependent uptake of BCG. These results reveal that oncogenic activation of macropinocytosis determines BCG uptake by bladder cancer cells, implying that tumor responsiveness to BCG may be governed by the specific mutations present in the treated cancer cell. Cancer Res; 73(3); 1156–67. Ó2013 AACR. Introduction Despite more than 30 years of clinical experience with Bladder cancer is among the most common tumors diag- intravesical BCG for bladder cancer, its mechanism of antitu- nosed in the United States, with an estimated annual incidence mor effect remains unknown and no markers exist to predict of 70,530 new cases and 14,680 deaths in 2010 (1).
    [Show full text]
  • Role of Rac1-Pak Pathway in Aggressive B-Cell Lymphoma
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-4-2019 Role of Rac1-Pak pathway in aggressive b-cell lymphoma Tian Tian University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Hemic and Lymphatic Diseases Commons, and the Neoplasms Commons Recommended Citation Tian, Tian, "Role of Rac1-Pak pathway in aggressive b-cell lymphoma" (2019). Theses & Dissertations. 344. https://digitalcommons.unmc.edu/etd/344 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. i Role of Rac1-PAK Pathway in Aggressive B-cell Lymphomas By Tian Tian A DISSERTATION Presented to the Faculty of The University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Pathology & Microbiology Graduate program Under the Supervision of Professor Kai Fu University of Nebraska Medical Center, Omaha, Nebraska Dec, 2018 Supervisory Committee: Ying Yan, Ph.D. John S Davis, Ph.D. Timothy C Greiner, M.D. Javeed Iqbal, Ph.D. ii Role of Rac1-PAK pathway in Aggressive B-cell Lymphomas Tian Tian University of Nebraska Medical Center, 2018 Advisor: Kai Fu, M.D. Ph.D. Aggressive B-cell lymphomas are diverse group of neoplasms that arise at different stages of B-cell development and by various mechanisms of neoplastic transformation. Aggressive B-cell lymphomas include many types, subtypes and variants of diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), mantle cell lymphoma (MCL) and B lymphoblastic lymphoma.
    [Show full text]
  • Whole Exome Sequencing of Thymic Neuroendocrine Tumor with Ectopic
    176:2 Y Li, Y Peng and others Sequencing thymic 176:2 187–194 Clinical Study neuroendocrine tumor Whole exome sequencing of thymic neuroendocrine tumor with ectopic ACTH syndrome Yanli Li1,*, Ying Peng1,*, Xiuli Jiang1, Yulong Cheng3, Weiwei Zhou1, Tingwei Su1, Jing Xie2, Xu Zhong1, Dalong Song1, Luming Wu1, Liwen Fan1, Min Li1, Jie Hong1, Weiqing Wang1, Guang Ning1,3 and Yanan Cao1 1Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Key Laboratory for Endocrine Tumors and 2Department of Pathology, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China, and 3Laboratory of Endocrinology and Metabolism, Institute of Health Correspondence Sciences, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS) & should be addressed Shanghai Jiao-Tong University School of Medicine (SJTUSM), Shanghai, China to Y Cao *(Y Li and Y Peng contributed equally to this work) Email [email protected] Abstract Objective: Thymic neuroendocrine tumor is the second-most prevalent cause of ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS), which is a rare disease characterized by ectopic ACTH oversecretion from nonpituitary tumors. However, the genetic abnormalities of thymic neuroendocrine tumors with EAS remain largely unknown. We aim to elucidate the genetic abnormalities and identify the somatic mutations of potential tumor-related genes of thymic neuroendocrine tumors with EAS by whole exome sequencing. Design and methods: Nine patients with thymic neuroendocrine tumors with EAS who were diagnosed at Shanghai Clinical Center for Endocrine and Metabolic Diseases in Ruijin Hospital between 2002 and 2014 were enrolled. We performed whole exome sequencing on the DNA obtained from thymic neuroendocrine tumors and matched peripheral blood using the Hiseq2000 platform.
    [Show full text]
  • Supplementary Table S2
    1-high in cerebrotropic Gene P-value patients Definition BCHE 2.00E-04 1 Butyrylcholinesterase PLCB2 2.00E-04 -1 Phospholipase C, beta 2 SF3B1 2.00E-04 -1 Splicing factor 3b, subunit 1 BCHE 0.00022 1 Butyrylcholinesterase ZNF721 0.00028 -1 Zinc finger protein 721 GNAI1 0.00044 1 Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 GNAI1 0.00049 1 Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 PDE1B 0.00069 -1 Phosphodiesterase 1B, calmodulin-dependent MCOLN2 0.00085 -1 Mucolipin 2 PGCP 0.00116 1 Plasma glutamate carboxypeptidase TMX4 0.00116 1 Thioredoxin-related transmembrane protein 4 C10orf11 0.00142 1 Chromosome 10 open reading frame 11 TRIM14 0.00156 -1 Tripartite motif-containing 14 APOBEC3D 0.00173 -1 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D ANXA6 0.00185 -1 Annexin A6 NOS3 0.00209 -1 Nitric oxide synthase 3 SELI 0.00209 -1 Selenoprotein I NYNRIN 0.0023 -1 NYN domain and retroviral integrase containing ANKFY1 0.00253 -1 Ankyrin repeat and FYVE domain containing 1 APOBEC3F 0.00278 -1 Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F EBI2 0.00278 -1 Epstein-Barr virus induced gene 2 ETHE1 0.00278 1 Ethylmalonic encephalopathy 1 PDE7A 0.00278 -1 Phosphodiesterase 7A HLA-DOA 0.00305 -1 Major histocompatibility complex, class II, DO alpha SOX13 0.00305 1 SRY (sex determining region Y)-box 13 ABHD2 3.34E-03 1 Abhydrolase domain containing 2 MOCS2 0.00334 1 Molybdenum cofactor synthesis 2 TTLL6 0.00365 -1 Tubulin tyrosine ligase-like family, member 6 SHANK3 0.00394 -1 SH3 and multiple ankyrin repeat domains 3 ADCY4 0.004 -1 Adenylate cyclase 4 CD3D 0.004 -1 CD3d molecule, delta (CD3-TCR complex) (CD3D), transcript variant 1, mRNA.
    [Show full text]
  • HCC and Cancer Mutated Genes Summarized in the Literature Gene Symbol Gene Name References*
    HCC and cancer mutated genes summarized in the literature Gene symbol Gene name References* A2M Alpha-2-macroglobulin (4) ABL1 c-abl oncogene 1, receptor tyrosine kinase (4,5,22) ACBD7 Acyl-Coenzyme A binding domain containing 7 (23) ACTL6A Actin-like 6A (4,5) ACTL6B Actin-like 6B (4) ACVR1B Activin A receptor, type IB (21,22) ACVR2A Activin A receptor, type IIA (4,21) ADAM10 ADAM metallopeptidase domain 10 (5) ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 (4) ADCY2 Adenylate cyclase 2 (brain) (26) AJUBA Ajuba LIM protein (21) AKAP9 A kinase (PRKA) anchor protein (yotiao) 9 (4) Akt AKT serine/threonine kinase (28) AKT1 v-akt murine thymoma viral oncogene homolog 1 (5,21,22) AKT2 v-akt murine thymoma viral oncogene homolog 2 (4) ALB Albumin (4) ALK Anaplastic lymphoma receptor tyrosine kinase (22) AMPH Amphiphysin (24) ANK3 Ankyrin 3, node of Ranvier (ankyrin G) (4) ANKRD12 Ankyrin repeat domain 12 (4) ANO1 Anoctamin 1, calcium activated chloride channel (4) APC Adenomatous polyposis coli (4,5,21,22,25,28) APOB Apolipoprotein B [including Ag(x) antigen] (4) AR Androgen receptor (5,21-23) ARAP1 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 (4) ARHGAP35 Rho GTPase activating protein 35 (21) ARID1A AT rich interactive domain 1A (SWI-like) (4,5,21,22,24,25,27,28) ARID1B AT rich interactive domain 1B (SWI1-like) (4,5,22) ARID2 AT rich interactive domain 2 (ARID, RFX-like) (4,5,22,24,25,27,28) ARID4A AT rich interactive domain 4A (RBP1-like) (28) ARID5B AT rich interactive domain 5B (MRF1-like) (21) ASPM Asp (abnormal
    [Show full text]
  • 4 Understanding the Role of GNA13 Deregulation in Lymphomagenesis
    Integrative Genomics Reveals a Role for GNA13 in Lymphomagenesis by Adrienne Greenough University Program in Genetics and Genomics Duke University Approved: ___________________________ Sandeep Dave, Supervisor ___________________________ Fred Dietrich ___________________________ Jack Keene ___________________________ Yuan Zhuang Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the University Program in Genetics and Genomics in the Graduate School of Duke University 2014 i v ABSTRACT Integrative Genomics Reveals a Role for GNA13 in Lymphomagenesis by Adrienne Greenough University Program in Genetics and Genomics Duke University Approved: ___________________________ Sandeep Dave, Supervisor ___________________________ Fred Dietrich ___________________________ Jack Keene ___________________________ Yuan Zhuang An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the University Program in Genetics and Genomics in the Graduate School of Duke University 2014 Copyright by Adrienne Greenough 2014 Abstract Lymphomas comprise a diverse group of malignancies derived from immune cells. High throughput sequencing has recently emerged as a powerful and versatile method for analysis of the cancer genome and transcriptome. As these data continue to emerge, the crucial work lies in sorting through the wealth of information to hone in on the critical aspects that will give us a better understanding of biology and new insight for how to treat disease. Finding the important signals within these large data sets is one of the major challenges of next generation sequencing. In this dissertation, I have developed several complementary strategies to describe the genetic underpinnings of lymphomas. I begin with developing a better method for RNA sequencing that enables strand-specific total RNA sequencing and alternative splicing profiling in the same analysis.
    [Show full text]
  • Characterization of the Macrophage Transcriptome in Glomerulonephritis-Susceptible and -Resistant Rat Strains
    Genes and Immunity (2011) 12, 78–89 & 2011 Macmillan Publishers Limited All rights reserved 1466-4879/11 www.nature.com/gene ORIGINAL ARTICLE Characterization of the macrophage transcriptome in glomerulonephritis-susceptible and -resistant rat strains K Maratou1, J Behmoaras2, C Fewings1, P Srivastava1, Z D’Souza1, J Smith3, L Game4, T Cook2 and T Aitman1 1Physiological Genomics and Medicine Group, MRC Clinical Sciences Centre, Imperial College London, London, UK; 2Centre for Complement and Inflammation Research, Imperial College London, London, UK; 3Renal Section, Imperial College London, London, UK and 4Genomics Laboratory, MRC Clinical Sciences Centre, London, UK Crescentic glomerulonephritis (CRGN) is a major cause of rapidly progressive renal failure for which the underlying genetic basis is unknown. Wistar–Kyoto (WKY) rats show marked susceptibility to CRGN, whereas Lewis rats are resistant. Glomerular injury and crescent formation are macrophage dependent and mainly explained by seven quantitative trait loci (Crgn1–7). Here, we used microarray analysis in basal and lipopolysaccharide (LPS)-stimulated macrophages to identify genes that reside on pathways predisposing WKY rats to CRGN. We detected 97 novel positional candidates for the uncharacterized Crgn3–7. We identified 10 additional secondary effector genes with profound differences in expression between the two strains (45-fold change, o1% false discovery rate) for basal and LPS-stimulated macrophages. Moreover, we identified eight genes with differentially expressed alternatively spliced isoforms, by using an in-depth analysis at the probe level that allowed us to discard false positives owing to polymorphisms between the two rat strains. Pathway analysis identified several common linked pathways, enriched for differentially expressed genes, which affect macrophage activation.
    [Show full text]
  • Supplemental Digital Content (Sdc) Sdc, Materials
    SUPPLEMENTAL DIGITAL CONTENT (SDC) SDC, MATERIALS AND METHODS Animals This study used 9-12 week old male C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME). This study conformed to the National Institutes of Health guidelines and was conducted under animal protocols approved by the University of Virginia’s Institutional Animal Care and Use Committee. Murine DCD Lung Procedure Mice were anesthetized by isoflurane inhalation and euthanized by cervical dislocation followed by a 60-minute period of “no-touch” warm ischemia. Mice then underwent extended median sternotomy and midline cervical exposure followed by intubation for the initiation of mechanical ventilation at 120 strokes/minute with room air. The left atrium was vented via an atriotomy followed by infusion of the lungs with 3 mL 4°C Perfadex® solution (Vitrolife Inc., Denver, CO) supplemented with THAM Solution (Vitrolife, Kungsbacka, Sweden), estimating weight-based volume recommendations for pulmonary artery perfusion (140mL/kg) (1). The chest was then packed with ice and the trachea occluded by silk-suture tie at tidal volume (7µL/g body weight) prior to cold static preservation (CSP) for 60 minutes at 4°C. Mice were then randomized into three experimental groups: 1) CSP alone with no EVLP, 2) EVLP with Steen solution and 3) EVLP with Steen solution supplemented with the highly selective A2AR agonist, ATL1223 (30nM, Lewis and Clark Pharmaceuticals, Charlottesville, VA). Mice treated with ATL1223 during EVLP also received ATL1223 treatment (30nM) during the Perfadex flush prior to CSP whereas the EVLP group received vehicle (DMSO) during the flush. CSP lungs, which did not undergo EVLP, underwent immediate functional assessment after re-intubation as described below.
    [Show full text]
  • HHS Public Access Author Manuscript
    HHS Public Access Author manuscript Author Manuscript Author ManuscriptBreast Cancer Author Manuscript Res Treat Author Manuscript . Author manuscript; available in PMC 2016 June 01. Published in final edited form as: Breast Cancer Res Treat. 2015 June ; 151(2): 453–463. doi:10.1007/s10549-015-3401-8. Body mass index associated with genome-wide methylation in breast tissue Brionna Y. Hair1, Zongli Xu2, Erin L. Kirk1, Sophia Harlid2, Rupninder Sandhu3, Whitney R. Robinson1,3, Michael C. Wu4, Andrew F. Olshan1, Kathleen Conway1,3, Jack A. Taylor2, and Melissa A. Troester1 1 Department of Epidemiology, University of North Carolina at Chapel Hill, CB #7435, 2101 McGavran-Greenberg Hall, Chapel Hill, NC 27599-7435, USA 2 Epidemiology Branch, and Epigenomics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences (NIH), Research Triangle Park, NC, USA 3 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 4 Fred Hutchinson Cancer Research Center, Seattle, WA, USA Abstract Gene expression studies indicate that body mass index (BMI) is associated with molecular pathways involved in inflammation, insulin-like growth factor activation, and other carcinogenic processes in breast tissue. The goal of this study was to determine whether BMI is associated with gene methylation in breast tissue and to identify pathways that are commonly methylated in association with high BMI. Epigenome-wide methylation profiles were determined using the Illumina HumanMethylation450 BeadChip array in the non-diseased breast tissue of 81 women undergoing breast surgery between 2009 and 2013 at the University of North Carolina Hospitals. Multivariable, robust linear regression was performed to identify methylation sites associated with BMI at a false discovery rate q value <0.05.
    [Show full text]
  • Whole Transcriptomic Expression Differences in EBV Immortalized Versus Primary B-Cells
    W&M ScholarWorks Undergraduate Honors Theses Theses, Dissertations, & Master Projects 12-2010 Whole Transcriptomic Expression Differences in EBV Immortalized versus Primary B-Cells Dolores Huberts College of William and Mary Follow this and additional works at: https://scholarworks.wm.edu/honorstheses Part of the Biology Commons Recommended Citation Huberts, Dolores, "Whole Transcriptomic Expression Differences in EBV Immortalized versus Primary B- Cells" (2010). Undergraduate Honors Theses. Paper 347. https://scholarworks.wm.edu/honorstheses/347 This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. Whole Transcriptomic Expression Differences in EBV Immortalized versus Primary B-Cells A thesis submitted in partial fulfillment of the requirement for the degree of Bachelor of Science with Honors in Biology from the College of William and Mary in Virginia By Dolores Huberts Accepted for Honors ________________________________________ Lizabeth A. Allison, Director ________________________________________ Matthew Wawersik ________________________________________ Drew LaMar ________________________________________ Beverly Sher Williamsburg, Virginia December 17, 2010 ABSTRACT The Epstein–Barr Virus (EBV) is a human gamma herpes virus that infects more than 90% of the human population worldwide. It is commonly known in the US as the cause of Infectious Mononucleosis, and around the world as the cause of nasopharyngeal carcinoma and malignant lymphomas such as non-Hodgkin lymphoma, endemic Burkett’s lymphoma and Hodgkin lymphoma. Additionally, the EBV is used to immortalize cells to create cell lines for in-vitro studies.
    [Show full text]